Biofrontera (BFRI) Set to Announce Earnings on Wednesday

Biofrontera (NASDAQ:BFRIGet Free Report) is scheduled to be releasing its earnings data on Wednesday, March 6th.

Biofrontera Stock Performance

NASDAQ BFRI opened at $0.90 on Tuesday. Biofrontera has a 52 week low of $0.61 and a 52 week high of $13.48. The stock has a market capitalization of $1.37 million, a price-to-earnings ratio of -0.04 and a beta of 0.54. The stock’s 50 day moving average price is $1.58 and its two-hundred day moving average price is $4.34.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. grew its holdings in shares of Biofrontera by 894.0% during the 1st quarter. BlackRock Inc. now owns 100,505 shares of the company’s stock worth $335,000 after purchasing an additional 90,394 shares in the last quarter. Northern Trust Corp acquired a new stake in shares of Biofrontera during the 2nd quarter worth $39,000. Renaissance Technologies LLC grew its holdings in shares of Biofrontera by 41.1% during the 2nd quarter. Renaissance Technologies LLC now owns 50,434 shares of the company’s stock worth $26,000 after purchasing an additional 14,700 shares in the last quarter. State Street Corp acquired a new stake in shares of Biofrontera during the 1st quarter worth $49,000. Finally, XTX Topco Ltd acquired a new stake in shares of Biofrontera during the 1st quarter worth $48,000. 58.40% of the stock is owned by institutional investors and hedge funds.

Biofrontera Company Profile

(Get Free Report)

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp.

Recommended Stories

Earnings History for Biofrontera (NASDAQ:BFRI)

Receive News & Ratings for Biofrontera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biofrontera and related companies with MarketBeat.com's FREE daily email newsletter.